Agilon Health, Inc.AGLNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +27.63% | +86.69% | -4.46% | -5.92% | -1.08% |
| Gross Profit Growth | -274.18% | +0.00% | -32.45% | -262.94% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -34.59% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.43% | +0.76% | +0.98% | +0.62% | +0.70% |
| Weighted Average Shares Diluted Growth | +1.43% | +0.76% | +0.98% | +0.62% | +0.70% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -420.45% |
| Receivables Growth | +1.68% | +7.91% | -21.10% | -27.13% | -30.78% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -8.19% | -0.40% | -16.56% | -20.82% | -23.68% |
| Book Value per Share Growth | -35.03% | -29.38% | -28.13% | -39.94% | -47.13% |
| Debt Growth | -15.17% | -15.96% | -12.37% | -10.40% | -15.45% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -12.40% | -5.57% | -13.70% | -19.15% | -17.45% |